Group One Trading
IGC icon

Group One Trading’s IGC Pharma IGC Stock Holding History

Group One Trading’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$989 Sell
3,762
-3,425
-48% -$950 ﹤0.01% 7215
2025
Q4 		$2.02K Hold
7,187
– – ﹤0.01% 7548
2025
Q3 		$3K Hold
7,187
– – ﹤0.01% 7770
2025
Q2 		$2.2K Hold
7,187
– – ﹤0.01% 7392
2025
Q1 		$2.05K Sell
7,187
-3,243
-31% -$1.02K ﹤0.01% 7001
2024
Q4 		$3.5K Sell
10,430
-10,979
-51% -$4.11K ﹤0.01% 6565
2024
Q3 		$9.14K Sell
21,409
-708
-3% -$284 ﹤0.01% 5644
2024
Q2 		$9.59K Sell
22,117
-15,189
-41% -$7.55K ﹤0.01% 5669
2024
Q1 		$14.9K Sell
37,306
-23,153
-38% -$7.19K ﹤0.01% 5626
2023
Q4 		$16.9K Sell
60,459
-1,100
-2% -$341 ﹤0.01% 5871
2023
Q3 		$22.1K Buy
61,559
+1,587
+3% +$568 ﹤0.01% 5817
2023
Q2 		$18.7K Sell
59,972
-184
-0.3% -$60 ﹤0.01% 6033
2023
Q1 		$20.4K Buy
60,156
+11,400
+23% +$4.28K ﹤0.01% 5496
2022
Q4 		$15.5K Buy
48,756
+17,703
+57% +$7.22K ﹤0.01% 5765
2022
Q3 		$13K Hold
31,053
– – ﹤0.01% 6339
2022
Q2 		$16K Buy
31,053
+4,255
+16% +$2.68K ﹤0.01% 6447
2022
Q1 		$25K Buy
+26,798
New +$26K ﹤0.01% 6611
2021
Q4 		– Sell
-12,521
Closed -$16.8K – 8479
2021
Q3 		$19K Sell
12,521
-36,819
-75% -$59.5K ﹤0.01% 7201
2021
Q2 		$81K Sell
49,340
-6,011
-11% -$9.18K ﹤0.01% 6162
2021
Q1 		$99K Buy
55,351
+29,662
+115% +$53.9K ﹤0.01% 5673
2020
Q4 		$40K Buy
+25,689
New +$38K ﹤0.01% 5147
2020
Q3 		– Sell
-4,149
Closed -$4.22K – 6293
2020
Q2 		$2K Buy
4,149
+3,800
+1,089% +$2.06K ﹤0.01% 5554
2020
Q1 		$0 Sell
349
-3,229
-90% -$1.79K ﹤0.01% 5482
2019
Q4 		$2K Buy
+3,578
New +$2.93K ﹤0.01% 4900

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading's IGC Position: Q1 2026 in Review

Group One Trading reduced its IGC Pharma (IGC) stake by 48% in Q1 2026, selling an estimated $950 and leaving 3,762 shares worth $989. The position accounts for ﹤0.01% of the portfolio, ranked #7215.

Group One Trading first reported a position in IGC in Q4 2019 and has held it in 24 quarters since. The position peaked at $99K in Q1 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Group One Trading held 3,762 shares of IGC Pharma worth $989 as of Q1 2026.
  • Group One Trading sold 3,425 IGC Pharma shares in Q1 2026, an estimated $950.
  • IGC Pharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7215 holding.
  • Group One Trading first reported a position in IGC Pharma in Q4 2019 and has held it in 24 quarters since.
  • Group One Trading's IGC Pharma position peaked at $99K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.